Page 141 - SPONDYLOARTHRITIS IN COLOMBIA -

87. Helliwell P.S. A randomised trial of three different physiotherapy regimes in ankylosing spondylitis. Abbott C.A., Chamberlain Ma. Physiotherapy. 1996; 82 (2): 85-90.
88. Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A. Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol. 1996;35(8):767-70.
89. Lehtinen A, Leirisalo-Repo M, Taavitsainen M. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up. Clin Exp Rheumatol. 1995;13(6):733-6.
90. Dougados M, vam der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, Zeidler H, Kvien TK, Olivieri I, Dijkmans B, et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum. 1995;38(5):618-27
91. Hidding A, van der Linden S, Gielen X, de Witte L, Dijkmans B, Moolenburgh D. Continuation of group physical therapy is necessary in ankylosing spondylitis: results of a randomized controlled trial. Arthritis Care Res. 1994;7(2):90-6.
92. Dougados M, Nguyen M, Caporal R, Legeais J, Bouxin-Sauzet A, Pellegri-Guegnault B, Gomeni C. Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study. Scand J Rheumatol. 1994;23(5):243-8.
93. Pasero G., Ruju G., Marcolongo R., Senesi M., Seni U., Mannoni A., Accardo S., Seriolo B., Colombo B., Ligniere G.C., Consoli G., De Santis D., Ferri S., Amoresano C., Frizziero L., Reta M., Giorgianni G., Martorana U., Termine S., Mattara L., Franceschini M., Oriente P., Scarpa R., Perpignano G., Bogliolo A., Torri G., Trotta F., Govoni F. Aceclofenac versus naproxen in the treatment of ankylosing spondylitis: A double-blind, controlled study. Current Therapeutic Research - Clinical and Experimental. 1994; 55 (7): 833-842.
94. Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol. 1993 Aug;32(8):729-33.
95. McKenna F. Efficacy of diclofenac/misoprostol vs diclofenac in the treatment of ankylosing spondylitis. Drugs. 1993;45 Suppl 1:24-30; discussion 36-7.
96. Peters ND, Ejstrup L. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol. 1992;21(3):134-8.
97. Samborski W., Sobieska M., Mackiewicz T., Stratz T., Mennet M., Muller W. Heat treatment, a cause of exacerbation in ankylosing spondylitis? Zeitschrift fur Rheumatologie. 1992; 51 (3): 127- 131
98. Taylor HG, Beswick EJ, Dawes PT. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol. 1991;10(1):43-8.
99. Basler HD, Rehfisch HP. Cognitive-behavioral therapy in patients with ankylosing spondylitis in a German self-help organization. J Psychosom Res. 1991;35(2-3):345-54.
139